Australia, Oct. 1 -- Neurocrine Biosciences Inc., owns the trademark (2567568) for 'CRENESSITY' and '4 PARALLELOGRAMS, ROUNDED- CORNER, INTERSECTING' till May 29, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions.], 42 [Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results.] and 44 [Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders.]
Type of Mark: Figurative
Date of Acceptance: July 23
Registration Advertised: Sept. 30
For further details contact P.C. Nadine H. Jacobson Fross Zelnick Lehrman & Zissu.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2567568.
Disclaimer: Curated by HT Syndication.
